Rein Therapeutics Inc.
XNAS: RNTX
Rein Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LT...
Read More
1.39
0.26
(23.01%)
224.9K
XNAS Volume
High volume+gain today
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Rein Therapeutics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..